Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised double blind 2-way crossover trial of intranasal GSK256066 and azelastine in seasonal allergic rhinitis
2007-005302-44Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GSK256066 and azelastine in seasonal allergic rhinitis (SAR) (2 arms), sponsored by GSK. Primary endpoint: Weighted mean total nasal symptom score. Started Jan 2008; status: completed.
02
Drugs
GSK256066azelastine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2007-005302-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005302-44.